ClinicalTrials.govpublic full text
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
hepatitis c, liver disease, chronic hepatitis c, deb025, alisporivir, ribavirin therapy, genotype 2/3 treatment naive patients, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 813263
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.